Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background— Higher levels of serum phosphate are associated with adverse cardiovascular outcomes, especially in the setting of overt hyperphosphatemia. Given the biological importance of phosphorus, it is plausible that higher levels of serum phosphate within the normal range may also be associated with adverse outcomes. Methods and Results— We performed a post hoc analysis of data from the Cholesterol And Recurrent Events (CARE) study. Baseline serum phosphate levels were measured in 4127 fasting participants who were randomized to receive pravastatin 40 mg daily or placebo and followed up for a median of 59.7 months. We used Cox proportional-hazards models to examine the association between serum phosphate and adverse clinical outcomes after adjustment for potential confounders. During nearly 60 months of follow-up, 375 participants died. A significant association was noted between baseline serum phosphate level and the age-, race-, and sex-adjusted risk of all-cause death (hazard ratio per 1 mg/dL, 1.27; 95% confidence interval, 1.02 to 1.58). After categorization based on baseline phosphate level (<2.5, 2.5 to 3.4, 3.5 to 3.9, and ≥4 mg/dL) and further adjustment, a graded independent relation between phosphate and death was observed ( P for trend=0.03). For instance, participants with serum phosphate ≥3.5 mg/dL had an adjusted hazard ratio for death of 1.27 (95% confidence interval, 1.02 to 1.59) compared with those with serum phosphate of <3.5 mg/dL. Higher levels of serum phosphate were also associated with increased risk of new heart failure, myocardial infarction, and the composite of coronary death or nonfatal myocardial infarction, but not the risk of stroke. Conclusions— We found a graded independent relation between higher levels of serum phosphate and the risk of death and cardiovascular events in people with prior myocardial infarction, most of whom had serum phosphate levels within the normal range. Given the ready availability and low cost of serum phosphate assays, this finding may prove clinically useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Self-citationMineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Rule, A. D., Larson, T. S., Bergstralh, E. J., Slezak, J. M., Jacobsen, S. J., & Cosio, F. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-12-200412210-00009 · Cited by 1,066
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?
Zittermann, A., Schleithoff, S. S., Tenderich, G., Berthold, H. K., Körfer, R., & Stehle, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02624-4 · Cited by 536
Cited by
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Shanahan, C. M., Crouthamel, M. H., Kapustin, A., & Giachelli, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.234914 · Cited by 958
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Regulation and Function of the FGF23/Klotho Endocrine Pathways
Martin, A., David, V., & Quarles, L. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00002.2011 · Cited by 594
Hu, M. C., Shiizaki, K., Kuro-o, M., & Moe, O. W. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183727 · Cited by 587
Moe, S. M., Zidehsarai, M. P., Chambers, M. A., Jackman, L. A., Radcliffe, J. S., Trevino, L. L., Donahue, S. E., & Asplin, J. R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05040610 · Cited by 564
Effects of Phosphate Binders in Moderate CKD
Block, G. A., Wheeler, D. C., Persky, M. S., Kestenbaum, B., Ketteler, M., Spiegel, D. M., Allison, M. A., Asplin, J., Smits, G., Hoofnagle, A. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030223 · Cited by 540
Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease
Kalantar-Zadeh, K., Gutekunst, L., Mehrotra, R., Kovesdy, C. P., Bross, R., Shinaberger, C. S., Noori, N., Hirschberg, R., Benner, D., Nissenson, A. R., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06080809 · Cited by 510
The emerging role of phosphate in vascular calcification
Giachelli, C. M. (2009) · Kidney International · doi:10.1038/ki.2008.644 · Cited by 493
Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Kendrick, J., Cheung, A. K., Kaufman, J. S., Greene, T., Roberts, W. L., Smits, G., & Chonchol, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121224 · Cited by 448
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Guidelines for the management of chronic kidney disease
Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Burns, K., Manns, B., White, C., Madore, F., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080351 · Cited by 420
Self-citationClinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Dietary Phosphorus Acutely Impairs Endothelial Function
Shuto, E., Taketani, Y., Tanaka, R., Harada, N., Isshiki, M., Sato, M., Nashiki, K., Amo, K., Yamamoto, H., Higashi, Y., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101106 · Cited by 399
Phosphorus Binders and Survival on Hemodialysis
Isakova, T., Gutie[Combining Acute Accent]rrez, O. M., Chang, Y., Shah, A., Tamez, H., Smith, K., Thadhani, R., & Wolf, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060609 · Cited by 375
Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
Foley, R. N., Collins, A. J., Herzog, C. A., Ishani, A., & Kalra, P. A. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020141 · Cited by 372
Intestinal Npt2b Plays a Major Role in Phosphate Absorption and Homeostasis
Sabbagh, Y., O'Brien, S. P., Song, W., Boulanger, J. H., Stockmann, A., Arbeeny, C., & Schiavi, S. C. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050559 · Cited by 346
Shinaberger, C. S., Greenland, S., Kopple, J. D., Van Wyck, D., Mehrotra, R., Kovesdy, C. P., & Kalantar-Zadeh, K. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26665 · Cited by 339
Sullivan, C., Sayre, S. S., Leon, J. B., Machekano, R., Love, T. E., Porter, D., Marbury, M., & Sehgal, A. R. (2009) · JAMA · doi:10.1001/jama.2009.96 · Cited by 319
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Wolf, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121293 · Cited by 308
Chronic Kidney Disease: A Clinical Model of Premature Aging
Stenvinkel, P., & Larsson, T. E. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.051 · Cited by 296
Gender-specific pathway differences in the human serum metabolome
Krumsiek, J., Mittelstrass, K., Do, K. T., Stückler, F., Ried, J., Adamski, J., Peters, A., Illig, T., Kronenberg, F., Friedrich, N., et al. (2015) · Metabolomics · doi:10.1007/s11306-015-0829-0 · Cited by 291
Chronic Kidney Disease–Mineral-Bone Disorder: A New Paradigm
Moe, S. M., Drüeke, T., Lameire, N., & Eknoyan, G. (2007) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.10.005 · Cited by 287
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Tonelli, M., Curhan, G., Pfeffer, M., Sacks, F., Thadhani, R., Melamed, M. L., Wiebe, N., & Muntner, P. (2009) · Circulation · doi:10.1161/circulationaha.109.851873 · Cited by 280
Self-citationFoley, R. N., Collins, A. J., Ishani, A., & Kalra, P. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.016 · Cited by 274
High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III
Chang, A. R., Lazo, M., Appel, L. J., Gutiérrez, O. M., & Grams, M. E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.073148 · Cited by 262
Kuro-o, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0722-7 · Cited by 256
Calvo, M. S., & Uribarri, J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.053934 · Cited by 255
. Prediction, progression and outcomes of chronic kidney disease in older adults.
Anderson, S., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kaysen, G. A., Kusek, J. W., Nayfield, S. G., Schmader, K., Tian, Y., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080860 · Cited by 218
Overview of the FGF23-Klotho axis
Kuro-o, M. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1260-4 · Cited by 162
“Hyperphosphatemia has been identified as a potent, independent riskof death [ 74 ].”
BackgroundDhingra, R., Gona, P., Benjamin, E. J., Wang, T. J., Aragam, J., D'Agostino, R. B., Kannel, W. B., & Vasan, R. S. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq106 · Cited by 108
Up-regulation of FGF23 release by aldosterone
Zhang, B., Umbach, A. T., Chen, H., Yan, J., Fakhri, H., Fajol, A., Salker, M. S., Spichtig, D., Daryadel, A., Wagner, C. A., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.034 · Cited by 91
Kuro-o, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy126 · Cited by 80
Processed and Unprocessed Red Meat Consumption and Risk of Heart Failure: Prospective Study of Men
Kaluza, J., Åkesson, A., & Wolk, A. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000921 · Cited by 70
“higher levels of serum phosphate were associated with increased risk of new HF and CHD events compared to participants with lower levels.(19) Also among ambulatory HF patients by gest on A ril 5, 2017 http://circheure.”
ResultMechanisms and Regulation of Intestinal Phosphate Absorption
Hernando, N., & Wagner, C. A. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170024 · Cited by 70
A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects
Mohammad, J., Scanni, R., Bestmann, L., Hulter, H. N., & Krapf, R. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017121254 · Cited by 60
High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis
Maique, J., Flores, B., Shi, M., Shepard, S., Zhou, Z., Yan, S., Moe, O. W., & Hu, M. C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01273 · Cited by 47
“Kidney fibrosis is one of the hallmarks of the aged kidney and of CKD, and also a deleterious driver for CKD progression (Cruz et al., 2000; Torres and Leof, 2011; Yang and Fogo, 2014; Humphreys, 2018).”
BackgroundElastolytic activity of cysteine cathepsins K, S, and V promotes vascular calcification
Andrault, P.-M., Panwar, P., Mackenzie, N. C. W., & Brömme, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-45918-1 · Cited by 43
Ratkovski, G. P., do Nascimento, K. T. O., Pedro, G. C., Ratkovski, D. R., Gorza, F. D. S., da Silva, R. J., Maciel, B. G., Mojica-Sánchez, L. C., & de Melo, C. P. (2020) · Langmuir · doi:10.1021/acs.langmuir.9b02901 · Cited by 40
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes
Abegaz, T. M., Baljoon, A., Kilanko, O., Sherbeny, F., & Ali, A. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107289 · Cited by 34
Volk, C., Schmidt, B., Brandsch, C., Kurze, T., Schlegelmilch, U., Grosse, I., Ulrich, C., Girndt, M., & Stangl, G. I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab635 · Cited by 21
Dai, L., Schurgers, L., Shiels, P. G., & Stenvinkel, P. (2021) · Clinical Science · doi:10.1042/cs20201452 · Cited by 11
Egli-Spichtig, D., Hamid, A. K., Arroyo, E. M. P., Ketteler, M., Wiecek, A., Rosenkranz, A. R., Pasch, A., Lorenz, H., Hellmann, B., Karus, M., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad040 · Cited by 9
Metadata
- Authors
- Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G.
- Venue
- Circulation
- Published
- 2005-10-25
- Volume
- 112
- Issue
- 17
- Pages
- 2627-2633
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2148134624
- Cited by
- 885
- References
- 27
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.